MyoKardia, Inc.
Pharmaceutical company · Brisbane, California, United States
MyoKardia, Inc. is a pharmaceutical company headquartered in Brisbane, California, United States. Its earliest recorded incorporation is in 2012. It has reported private securities offerings to the US SEC, most recently $46 million sold in a notice filed in 2015.
MyoKardia at a glance
What does MyoKardia do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $46 million sold (2015).
Frequently asked questions about MyoKardia
Where is MyoKardia headquartered?
MyoKardia, Inc. is headquartered in Brisbane, California, United States.
What does MyoKardia do?
MyoKardia, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was MyoKardia founded?
The earliest incorporation on record for MyoKardia, Inc. is in 2012, according to public company registers.
Similar companies
- Annexon, Inc.Brisbane, California, United States
- Day One Biopharmaceuticals, Inc.Brisbane, California, United States
- Vera Therapeutics, Inc.Brisbane, California, United States
- Tempest Therapeutics, Inc.Brisbane, California, United States
- Aimmune Therapeutics, Inc.Brisbane, California, United States
- Nurix Therapeutics, Inc.Brisbane, California, United States
- Dance Biopharm Inc.Brisbane, California, United States
- Intermune IncBrisbane, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences